Project Description

ANSES3

O ANSES3 – Evaluación no invasiva del sistema nervioso autónomo mediante análisis de la variabilidad de bioseñales. Aplicación a situaciones clínicas relacionadas con el estrés é um projeto que visa o desenvolvimento de tecnologia para personalização do tratamento, avaliação da eficácia da terapêutica e identificação da população de risco a partir da monitorização do sistema nervoso autónomo e da variabilidade de sinais biológicos em determinadas situações clínicas relacionadas com o stress.

Este projeto envolve uma equipa de investigação multidisciplinar, incluindo membros de hospitais e universidades que poderão garantir a transferência dos resultados, esperando-se uma redução dos custos dos sistemas de saúde e um elevado impacto social.

O financiamento total, que ronda os 153 mil euros, é da responsabilidade da Secretaria de Estado de Investigación, Desarrollo e Innovación de Espanha.

Abstract

Dysfunctions of the autonomic nervous system (ANS) have been associated with a variety of diseases including hypertension, heart failure, obesity, diabetes, sleep apnea and mental disorders, which are among the most prevalent diseases in Spain and in Europe, mainly in elderly people. Stress, which is mediated by ANS, has been related to worsen or negative outcome of most of those diseases, as well as of physiological performances. Assessment of ANS is a challenging and potential tool in the monitoring and evaluation of the former applications. Since ANS activity prints characteristic patterns in cardiovascular signals, noninvasive measurement and interpretation of ANS activity through the processing of such signals has been proposed.

In this project we aim at monitoring ANS response in stress-related clinical situations through the analysis of biological signals variability in order to decide best (personalized) treatment in pathological situations and the best planning in physiological situations. Clinical applications addressed in this project include physiological, pathological and psychological stress and are the following:

  • Identification of pregnant women at high risk of suffering hypotension during spinal anesthesia for cesarean delivery, which can benefit from prophylaxis, minimizing prophylaxis negative effects on fetuses.
  • Evaluation of obstructive sleep apnea impact on autonomic balance, related to
  • cardiovascular risk, as well as the effectiveness of the treatment in risk reduction.
  • Prediction of hypotension during hemodialysis to improve treatment effectiveness in endstage renal failure patients.
  • Determination of the relationship between ANS alterations, stress and the severity of two major diseases: depression and asthma.
  • Deriving fitness information from the ANS response to exercise-induced stress which can be used to evaluate and improve training programs.
  • Evaluation of the clinical value of heart rate variability (HRV) during exercise-induced stress in the diagnosis of coronary artery disease and in the prognosis of cardiovascular and allcause mortality.

To achieve the former objectives it is essential to develop techniques for the robust analysis of biological signals recorded in these stress-related situations, mainly HRV and pulse photoplethysmograpic signals, as well as for the physiologically-driven interpretation of the results.

This requires the joint and tight collaboration of technicians and clinicians, addressed by our multidisciplinary research team. The research and work teams include members from national and international hospitals and universities, with proven expertise in their respective fields.

The project will contribute to the research and development of technology for obtaining personalized treatment, therapy effectiveness evaluation, and identification of risk population, which will considerably reduce Health System costs. The participation of hospitals and companies interested in the project guarantees the potential application or transfer of the expected results. Results will have a high social impact as they will improve the outcome of highly prevalent diseases, being aligned with the societal challenge “Health, Demographic Change and Wellbeing” of Horizon 2020.

Líder do Projeto

Instituto de Investigación en Ingeniería en Aragón (Spain)

Entidade Financiadora

Secretaria de Estado de Investigación, Desarrollo e Innovación, Espanha

Montante global

153.307,00 €

Investigadores CINTESIS envolvidos

Rute Almeida, Ovídio Costa, João Bernardes